Sands Capital's position in Edwards Lifesciences is currently worth $1.35 Million. That's 0.00% of their equity portfolio (66th largest holding). The first Edwards Lifesciences trade was made in Q3 2015. Since then Sands Capital bought shares eight more times and sold shares on 29 occasions. The stake costed the investor $772 Thousand, netting the investor a gain of 75% so far.
EW Investors with Losses Encouraged to Contact the Firm Before Dec. 13, 2024 Deadline SAN FRANCISCO, CA / ACCESSWIRE / December 3, 2024 / Hagens Berman urges...
SAN FRANCISCO, Dec. 01, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...
SAN FRANCISCO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...
SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Edwards Lifesciences Corporation (NYSE: EW) investors who suffered substantial losses to...